Integrated Research Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Der Gewinn von Integrated Research wird voraussichtlich um 7.2% pro Jahr zurückgehen, während der Jahresumsatz um 9.9% pro Jahr wachsen soll. Der Gewinn je Aktie wird voraussichtlich um 9.6% pro Jahr sinken. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.2% betragen.

Wichtige Informationen

-7.2%

Wachstumsrate der Gewinne

-9.56%

EPS-Wachstumsrate

Software Gewinnwachstum	25.9%
Wachstumsrate der Einnahmen	9.9%
Zukünftige Eigenkapitalrendite	9.20%
Analystenabdeckung	Low
Zuletzt aktualisiert	26 Aug 2025

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Integrated Research (ASX:IRI) Is Paying Out A Dividend Of A$0.02

Aug 30

Some Investors May Be Worried About Integrated Research's (ASX:IRI) Returns On Capital

Aug 11

When Should You Buy Integrated Research Limited (ASX:IRI)?

Jun 16

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

May 09

Shifting To High-Value Clients And Launching IR Labs May Improve Stability, But Challenges Remain

Feb 09 Strategic focus on high-value enterprise customers and efficient cost management is expected to enhance net margins and revenue stability.

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Oct 22

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Aug 29

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Aug 21

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Jun 28

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Jun 11

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Apr 20

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Mar 02

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Apr 05

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Sep 27

Does Integrated Research (ASX:IRI) Have A Healthy Balance Sheet?

Aug 22

Integrated Research (ASX:IRI) Will Will Want To Turn Around Its Return Trends

Jun 14

Integrated Research (ASX:IRI) Seems To Use Debt Quite Sensibly

May 03

Gewinn- und Umsatzwachstumsprognosen

ASX:IRI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2028	92	11	N/A	9	1
6/30/2027	84	8	N/A	2	1
6/30/2026	77	6	N/A	2	1
6/30/2025	68	13	8	9	N/A
3/31/2025	70	17	9	9	N/A
12/31/2024	71	21	10	10	N/A
9/30/2024	77	24	11	12	N/A
6/30/2024	83	27	13	13	N/A
3/31/2024	78	3	13	15	N/A
12/31/2023	72	-21	13	16	N/A
9/30/2023	71	-25	10	15	N/A
6/30/2023	70	-29	6	14	N/A
3/31/2023	69	-13	2	12	N/A
12/31/2022	69	3	-1	9	N/A
9/30/2022	66	2	2	13	N/A
6/30/2022	63	2	5	17	N/A
3/31/2022	70	6	6	18	N/A
12/31/2021	77	10	7	18	N/A
9/30/2021	78	9	8	20	N/A
6/30/2021	78	8	9	21	N/A
3/31/2021	85	10	9	22	N/A
12/31/2020	92	12	9	22	N/A
9/30/2020	101	18	9	23	N/A
6/30/2020	111	24	9	24	N/A
3/31/2020	107	23	10	25	N/A
12/31/2019	104	22	11	25	N/A
9/30/2019	102	22	10	23	N/A
6/30/2019	101	22	9	21	N/A
3/31/2019	98	22	N/A	22	N/A
12/31/2018	96	22	N/A	23	N/A
9/30/2018	93	20	N/A	22	N/A
6/30/2018	91	19	N/A	21	N/A
3/31/2018	92	20	N/A	22	N/A
12/31/2017	94	20	N/A	23	N/A
9/30/2017	92	19	N/A	25	N/A
6/30/2017	91	19	N/A	26	N/A
3/31/2017	90	18	N/A	24	N/A
12/31/2016	88	18	N/A	22	N/A
9/30/2016	87	17	N/A	19	N/A
6/30/2016	85	16	N/A	16	N/A
3/31/2016	80	14	N/A	16	N/A
12/31/2015	76	13	N/A	17	N/A
9/30/2015	73	14	N/A	19	N/A
6/30/2015	70	14	N/A	21	N/A
3/31/2015	65	13	N/A	19	N/A
12/31/2014	61	12	N/A	16	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: IRIFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-7.2% pro Jahr).

Ertrag vs. Markt: IRIFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-7.2% pro Jahr).

Hohe Wachstumserträge: IRIFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: IRIDie Einnahmen des Unternehmens (9.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.8% pro Jahr).

Hohe Wachstumseinnahmen: IRIDie Einnahmen des Unternehmens (9.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: IRIDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.2%).

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2025/10/04 21:26
Aktienkurs zum Tagesende	2025/10/03 00:00
Gewinne	2025/06/30
Jährliche Einnahmen	2025/06/30

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Integrated Research Limited wird von 6 Analysten beobachtet. 1 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Chris Savage	Bell Potter
Katie Belle	Lodge Partners Pty Ltd.
Todd Guyot	MA Moelis Australia Securities Pty Ltd

Integrated Research Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 45%

Price target decreased by 13% to AU$0.70

Consensus EPS estimates fall by 21%

Integrated Research Limited Provides Revenue Guidance for the Full Year 2023

Consensus EPS estimates fall by 22%

Price target increased by 18% to AU$0.65

Recent updates

Integrated Research Limited, Annual General Meeting, Nov 24, 2025

Consensus EPS estimates fall by 45%

Integrated Research (ASX:IRI) Is Paying Out A Dividend Of A$0.02

Dividend of AU$0.02 announced

Full year 2025 earnings: EPS misses analyst expectations

Some Investors May Be Worried About Integrated Research's (ASX:IRI) Returns On Capital

Price target decreased by 13% to AU$0.70

Integrated Research Limited to Report Fiscal Year 2025 Results on Aug 21, 2025

When Should You Buy Integrated Research Limited (ASX:IRI)?

Integrated Research Announces Enhanced Cisco Cloud Migration Support

Integrated Research Limited (ASX:IRI) Shares Fly 29% But Investors Aren't Buying For Growth

First half 2025 earnings released: EPS: AU$0.026 (vs AU$0.064 in 1H 2024)

Shifting To High-Value Clients And Launching IR Labs May Improve Stability, But Challenges Remain

Consensus EPS estimates fall by 21%

Integrated Research Limited to Report First Half, 2025 Results on Feb 20, 2025

High number of new and inexperienced directors

Why Integrated Research Limited (ASX:IRI) Could Be Worth Watching

Integrated Research Limited Announces Company Secretary Changes

Integrated Research Appoints Ian Lowe as CEO

Impressive Earnings May Not Tell The Whole Story For Integrated Research (ASX:IRI)

Upcoming dividend of AU$0.02 per share

Integrated Research Limited Declares Fully Franked Final Dividend for the Year Ended June 30, 2024, Payable on October 15, 2024

Investors Don't See Light At End Of Integrated Research Limited's (ASX:IRI) Tunnel And Push Stock Down 37%

Integrated Research Limited, Annual General Meeting, Nov 27, 2024

New major risk - Revenue and earnings growth

Integrated Research Limited Announces the Appointment of Ian Lowe as the New Chief Executive Officer, Effective October 1, 2024

Now 22% overvalued after recent price rise

Integrated Research Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 26% overvalued after recent price rise

Now 22% overvalued after recent price rise

Integrated Research Limited (ASX:IRI) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Now 20% overvalued after recent price rise

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Why Investors Shouldn't Be Surprised By Integrated Research Limited's (ASX:IRI) Low P/S

Independent Non-Executive Director recently bought AU$98k worth of stock

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

First half 2024 earnings released: EPS: AU$0.064 (vs AU$0.019 in 1H 2023)

Integrated Research Limited to Report First Half, 2024 Results on Feb 22, 2024

Integrated Research Limited Announces Resignation of James Scott as Director, Effective 30 January 2024

Integrated Research Limited Announces Chief Financial Officer Changes

Integrated Research Limited Provides Revenue Guidance for the Full Year 2023

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Integrated Research Limited Announces the Appointment of Michael Hitz as Independent Non-Executive Director

Integrated Research Limited Announces Resignation of Allan Brackin as Director, Effective from 30 September 2023

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Full year 2023 earnings: EPS misses analyst expectations

Integrated Research Limited, Annual General Meeting, Nov 22, 2023

New minor risk - Financial data availability

Consensus EPS estimates fall by 22%

Integrated Research Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

First half 2023 earnings released: EPS: AU$0.019 (vs AU$0.01 in 1H 2022)

Price target increased by 18% to AU$0.65

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Price target increased to AU$0.55

Integrated Research Announces David Purdue to Retire as Company Secretary, Effective 30 September 2022

Now 23% undervalued after recent price drop

Integrated Research Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings released: EPS: AU$0.009 (vs AU$0.046 in FY 2021)

Now 22% undervalued after recent price drop

IR Appoints Rodney Foreman as Senior Vice President, Americas

Integrated Research Announces Executive Changes

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Integrated Research Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Integrated Research Limited Appoints Katrina Small as Chief People Officer

Now 23% undervalued after recent price drop

Integrated Research Limited Announces the Resignation of Peter Adams as Chief Financial Officer, Effective 31 August 2022